Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from MedAdvisor Limited ( (AU:MDR) ) is now available.
MedAdvisor Limited has entered into a non-binding Letter of Intent with a subsidiary of a major multinational software company to sell its ANZ business division and associated intellectual property. The potential transaction, valued at $35 million with an additional earn-out component, could significantly impact MedAdvisor’s operations and market positioning by aligning with a company that has a substantial market capitalization and revenue.
More about MedAdvisor Limited
MedAdvisor Limited is a global company specializing in pharmacy-driven patient engagement. The company operates primarily in the ANZ region under the MedAdvisor brand, focusing on enhancing patient engagement through innovative software solutions.
Average Trading Volume: 647,395
Technical Sentiment Signal: Sell
Current Market Cap: A$59.77M
Learn more about MDR stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money